Skip to main content
Helixmith Co., Ltd logo

Helixmith Co., Ltd — Investor Relations & Filings

Ticker · 084990 ISIN · KR7084990001 KO Manufacturing
Open in API
Filings indexed 508 across all filing types
Latest filing 2026-05-15 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 084990

About Helixmith Co., Ltd

https://www.helixmith.com/

Helixmith is a biotechnology company specializing in the research and development of gene therapies. Established in 1996, the company focuses on creating innovative biopharmaceuticals for diseases with significant unmet medical needs. Its core activities revolve around an extensive pipeline of next-generation gene therapy products. The primary therapeutic areas of focus include neurological and cardiovascular disorders, such as peripheral artery disease and coronary artery disease. Helixmith manages a comprehensive range of capabilities, from discovery and preclinical studies to clinical development of its drug candidates.

Recent filings

Filing Released Lang Actions
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서” (Korean for “Quarterly Report”) covering the period Jan 1 2026 to Mar 31 2026, includes full financial tables, business overview, R&D details, and substantive financial data. It is a complete interim/quarterly report rather than an announcement, transcript, or certification. Therefore it matches the Interim/Quarterly Report category. Q1 2026
2026-05-15 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is titled '주식등의 대량보유상황보고서' which translates to 'Report on Large Shareholding Status'. It contains detailed information about shareholdings, changes in share ownership, and related disclosures for a specific individual and related parties. The document references legal requirements under the Capital Markets Act and includes detailed tables of share quantities, ownership percentages, and transaction dates. There is no indication that this is an annual report, earnings release, or any other financial statement. Instead, it is a regulatory filing disclosing significant share ownership and changes thereof, which aligns with the definition of a Major Shareholding Notification (MRQ). The document length is substantial and contains actual data, not just an announcement or certification, so it is not a Regulatory Filing (RNS) or Report Publication Announcement (RPA). Therefore, the correct classification is MRQ.
2026-05-04 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document provides detailed outcomes of an annual general meeting, including approval of financial statements, dividend resolutions, board composition changes, and vote tallies for each agenda item. This is a direct declaration of voting results from the shareholder meeting, matching the “Declaration of Voting Results & Voting Rights Announcements” category.
2026-03-30 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 90% confidence The document is a Korean regulatory notice addressed to the Financial Services Commission/Korea Exchange, titled “사외이사의 선임·해임 또는 중도퇴임에 관한 신고,” detailing the appointment of an outside director, with form fields for director changes. This clearly falls under announcements of changes in the company’s board of directors, matching the Board/Management Information category.
2026-03-30 Korean
사업보고서 (2025.12)
Audit Report / Information Classification · 100% confidence The document is a formal 'Audit Report' (감사보고서) for Helixmith (주식회사 헬릭스미스) for the fiscal year ending December 31, 2025. It includes the independent auditor's opinion, financial statements (Balance Sheet, Income Statement, Statement of Changes in Equity, Cash Flow Statement), and detailed notes (주석). This is a comprehensive financial audit document, not an earnings release or a summary report, and it is clearly the full audit report itself. FY 2025
2026-03-20 Korean
감사보고서제출
Audit Report / Information Classification · 99% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) titled 'Audit Report Submission' (감사보고서 제출). It provides the auditor's opinion (unqualified/appropriate), key financial data (assets, liabilities, equity, profit/loss), and specific regulatory disclosures required for listed companies in Korea. While it contains financial data, it is a summary disclosure of the audit results rather than the full annual report (10-K) or a standalone audit report (AR). In the context of Korean regulatory filings (DART/KIND), this is a standard 'Audit Report Submission' announcement, which falls under the 'Regulatory Filings' category as it serves as a formal notification of the audit outcome. FY 2025
2026-03-18 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.